Notice of unauthorized access that may involve personal information | Learn more: English - Español

If you’re like many physicians today, you might think patients with Type B aortic dissection (TBAD) can only be treated with medical management or open chest surgery.  New research is showing that these patients might have another option.

Enter TEVAR. Short for thoracic endovascular aortic repair, this percutaneous procedure involves placing a stent graft into the aorta to restore blood flow to the true lumen. It’s a minimally invasive, endovascular alternative to open surgery.

Medical management for acute uncomplicated TBAD is still indicated. But recent clinical trials like the INSTEAD and ADSORB trials are showing that pairing medical management with TEVAR is leading to improved survival and better patient outcomes compared to medical management alone.

Pioneering Care in Aortic and Vascular Disease

Sanger Heart & Vascular Institute’s Center for Aortic Disease is leading the way in endovascular aortic repair.

  • Nationally ranked as the No. 1 center for EVAR volumes and a Top 5 center TEVAR volumes, performing more than 1,000 TEVAR and EVAR procedures since 2014
  • First team in the world to implant a branched stent graft to repair aortic arch aneurysms
  • Only center in the region to participate in both MONA LSA and Zone Zero clinical trials exploring the latest endovascular devices to treat aortic arch pathology
  • One of only two centers in North Carolinas with integrated, system-wide treatment protocols for ruptured aneurysms and thoracic aortic dissections

Contact Us

To make a referral or contact the Center for Aortic Disease, call 704-446-2256.

Close